You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute promyelocytic leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)

Recruiting
  • Newly-diagnosed APL (de Novo or Therapy-related)
  • Relapsed APL
  • observational
  • Dresden, Germany
    Prof. Dr. U. Platzbecker
Aug 10, 2022

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Birmingham, Alabama
    • +4 more
    Jul 12, 2022

    DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
    • +8 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Jul 12, 2022

    Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

    Recruiting
    • Promyelocytic Leukemia
    • Arsenic trioxide
    • all-trans retinoic acid
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Aug 9, 2022

    RWE of 1st Line Treatment With ATO/ATRA for Adult APL

    Recruiting
    • Promyelocytic Leukemia, Adult Acute
    • Evaluation of first line treatment with ATO/ATRA outcome
    • Caba, Argentina
    • +1 more
    Nov 9, 2021

    Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Realgar-Indigo naturalis formula
    • +3 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 31, 2021

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Brussels, Belgium
    • +30 more
    Aug 9, 2022

    Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

    Completed
    Has Results
    • Acute Promyelocytic Leukemia
    • Tretinoin and Arsenic Trioxide
    • Los Angeles, California
    • +11 more
    Nov 2, 2021

    Leukemia Trial in Tianjin (DNR:, Ara-c)

    Completed
    Has Results
    • Leukemia
    • Tianjin, Tianjin, China
    • +1 more
    Aug 8, 2021

    Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

    Recruiting
    • Acute Promyelocytic Leukemia
    • Arsenic Trioxide
    • Alessandria, Italy
    • +27 more
    Dec 31, 2021

    Results From a Mexican Acute Promyelocytic Leukemia.

    Completed
    • Promyelocytic Leukemia, Acute
    • Diagnosis
    • +2 more
    • Mexico, Mexico City, Mexico
      Nidia Zapata
    Sep 18, 2020

    Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Oral arsenic Trioxide, ATRA and ascorbic acid
    • Hong Kong, N/A = Not Applicable, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Nov 3, 2020

    Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO

    Active, not recruiting
    • Acute Promyelocytic Leukemia
    • QoL questionnaires
    • Ascoli Piceno, Italy
    • +15 more
    Feb 3, 2021

    Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Oral Arsenic Trioxide Formulation
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Dec 29, 2020

    Acute Promyelocytic Leukemia Trial in Bari, Pavia, Roma (all-trans retinoic acid (ATRA))

    Recruiting
    • Acute Promyelocytic Leukemia
    • all-trans retinoic acid (ATRA)
    • Bari, Italy
    • +2 more
    Oct 12, 2020

    Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

    Completed
    • Leukemia
    • arsenic trioxide
    • +5 more
    • Innsbruck, Austria
    • +109 more
    Oct 10, 2022

    Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

    Active, not recruiting
    • Leukemia
    • +2 more
    • laboratory biomarker analysis
    • San Diego, California
    • +50 more
    Aug 16, 2021

    AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

    Recruiting
    • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
    • MRD-triggered arm
    • Prophylactic Arm
    • Heidelberg, BW, Germany
      University Hospital Heidelberg Med5
    Jan 4, 2021

    Safety and Efficacy Trial in Suzhou (Ruxolitinib)

    Unknown status
    • Safety and Efficacy
    • Suzhou, Jiangsu, China
      First Affiliated Hospital, Soochow University
    Jun 22, 2020

    Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • +5 more
    • Biopsy
    • +7 more
    • Lewes, Delaware
    • +42 more
    Mar 15, 2022

    Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

    Active, not recruiting
    Has Results
    • Childhood Acute Promyelocytic Leukemia (M3)
    • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    • arsenic trioxide
    • +7 more
    • Birmingham, Alabama
    • +110 more
    Mar 23, 2022